The AAM’s Giuseppe Randazzo warns that the generics business could become unsustainable in the future if the market dynamics ...

Entresto generics have finally arrived in the U.S. in July, and approximately 9% of Novartis' revenue will be impacted. Learn ...

The U.S. is over-reliant on foreign-made generic drugs, which poses a threat to national security and has resulted in the ...

US President Donald Trump’s latest tariff order imposing a 100 percent levy on branded or patented pharmaceuticals is unlikely to dent India’s drug exports, which primarily comprises of generics or ...

US President Donald Trump announced on Friday that his administration will impose a 100% tariff on branded and patented pharmaceuticals starting October 1, 2025, unless companies set up production in ...

In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. AbbVie Inc. stands second among them. AbbVie Inc. (NYSE:ABBV), a global biopharmaceutical leader known for ...

The Controller General of Patents, Designs and Trademarks (CGPDTM), the Indian Patent Office, has annulled the patent granted to Novartis for its cardiac drug Vymada, also sold internationally as ...

As part of a new trade agreement with the U.S. and Japan, the Trump administration is exempting generic pharmaceuticals, their ingredients and chemical precursors from the 15% baseline tariff applied ...

The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made ...

Some Chinese companies now catapulting ahead to make generic versions of Novo Nordisk's Wegovy also provided ingredients for more than a billion makeshift doses of weight-loss drugs sold online in the ...